Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingxin Meng

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Inflammation|October 22, 2024
Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 PathwayYuming Liu, Zhigang Liu, Xiaohe Li, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Radiosynthesis and Evaluation of <sup>18</sup>F‑Labeled Deuterated Radioligand for Positron Emission Tomography Imaging of Cholesterol 24-HydroxylaseYinlong Li, Zhendong Song, Haofeng Shi, et al.
International Immunopharmacology|June 4, 2025
Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathwayZhongyi Yang, Zhiyi Li, Zhigang Liu, et al.
Signal Transduction and Targeted Therapy|December 1, 2025
A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinibYuankai Shi, Dongqing Lv, Weineng Feng, et al.
Marine Biotechnology (New York, N.Y.)|April 25, 2026
Environmental Exosomes/Small Extracellular Vesicles: Evidence of Extracellular RNA Release by Aquatic OrganismsRyo Yonezawa, Lingxin Meng, Naoki Hashimoto, et al.
Biochemical Pharmacology|May 18, 2024
Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathwayShimeng Li, Zhichao Liu, Xiaodan Jiao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2023
Development of [<sup>177</sup>Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expressionXuejun Wen, Pengfei Xu, Xinying Zeng, et al.
Physical Review Letters|March 25, 2025
Establishing a New Benchmark in Quantum Computational Advantage with 105-qubit Zuchongzhi 3.0 ProcessorDongxin Gao, Daojin Fan, Chen Zha, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Inflammation|October 22, 2024
Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 PathwayYuming Liu, Zhigang Liu, Xiaohe Li, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Radiosynthesis and Evaluation of <sup>18</sup>F‑Labeled Deuterated Radioligand for Positron Emission Tomography Imaging of Cholesterol 24-HydroxylaseYinlong Li, Zhendong Song, Haofeng Shi, et al.
International Immunopharmacology|June 4, 2025
Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathwayZhongyi Yang, Zhiyi Li, Zhigang Liu, et al.
Signal Transduction and Targeted Therapy|December 1, 2025
A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinibYuankai Shi, Dongqing Lv, Weineng Feng, et al.
Marine Biotechnology (New York, N.Y.)|April 25, 2026
Environmental Exosomes/Small Extracellular Vesicles: Evidence of Extracellular RNA Release by Aquatic OrganismsRyo Yonezawa, Lingxin Meng, Naoki Hashimoto, et al.
Biochemical Pharmacology|May 18, 2024
Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathwayShimeng Li, Zhichao Liu, Xiaodan Jiao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 25, 2023
Development of [<sup>177</sup>Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expressionXuejun Wen, Pengfei Xu, Xinying Zeng, et al.
Physical Review Letters|March 25, 2025
Establishing a New Benchmark in Quantum Computational Advantage with 105-qubit Zuchongzhi 3.0 ProcessorDongxin Gao, Daojin Fan, Chen Zha, et al.
Pageof 8